The trademark was filed by Perrigo Pharma International Designated Activity Company, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on February 19, 2020, and received one opposition filed on May 19, 2020 by THERABEL PHARMA NV on Likelihood of confusion. the opponent was represented by KIRKPATRICK, SA/NV and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 19, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Licences granted of the trademark registration was recorded on July 8, 2020. Deletion of the representative of the trademark registration was recorded on January 6, 2021. A transfer of the trademark registration was recorded on February 25, 2021. Change of name and professional address of the trademark registration was recorded on April 16, 2024.
The Opposition with reference B 003121820 was rejected according to Article 8(1)(b) EUTMR with decision issued on August 24, 2021 by the EUIPO.